Literature DB >> 981319

Neuroendocrine studies of depressive illness.

E J Sachar, H P Roffwarg, P H Gruen, N Altman, J Sassin.   

Abstract

Interest in possible neuroendocrine disturbances in endogenous depression is prompted by two lines of evidence: (1) clinical features of the illness suggest hypothalamic dysfunction; (2) the brain neurotransmitters implicated in depression also regulate neuroendocrine function. Our research reveals a marked, sustained hypersecretion in cortisol in severe depressive illness, which is apparently unrelated to stress and sleep disturbance, and which is associated with a distortion of the 24-hour cortisol secretory pattern. The hypersecretion is manifested primarily in the late afternoon, evening, and early morning hours, when cortisol secretion is normally inhibited. Growth hormone responses to hypoglycemia (but not to L-dopa) are also significantly reduced in endogenous depression, even when factors of age and the menopause are controlled. Postmenopausal depressed women appear to secret significantly less LH than normal postmenopausal women. Since all of these hormonal abnormalities can be reproduced by depletion of brain noradrenalin, the findings provide support for the the hypothesis of reduced functional noradrenergic activity in certain forms of depression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 981319     DOI: 10.1055/s-0028-1094472

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN: 0031-7098


  3 in total

Review 1.  A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.

Authors:  Erin E Sundermann; Pauline M Maki; Jeffrey R Bishop
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice.

Authors:  Divya Anchan; Sara Clark; Kevin Pollard; Nandini Vasudevan
Journal:  Brain Behav       Date:  2013-11-27       Impact factor: 2.708

3.  Epigenetic Risk Factors in PTSD and Depression.

Authors:  Florian Joachim Raabe; Dietmar Spengler
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.